SSpectrum Vascular makes medical devices that help with vascular access and medication delivery while reducing infections. Its products include central venous catheters, PICCs, midlines, arterial lines, and intraosseous needles that feature antimicrobial protection and designs to lower clot risks, with SV Spectrum and SV BioFlo technologies guiding care. The company differentiates itself by building a broad, integrated product line through acquisitions from Cook Medical (2023) and AngioDynamics (2024), creating a complete platform for care along the continuum. Its goal is to grow operations and improve patient outcomes by providing evidence-based vascular access and medication-management solutions backed by private investment and strategic leadership.
Work here?Claim your company
Industries
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
White Plains, NY
Founded
N/A
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Vitaquest welcomes Martin Gargiule as Chief Financial Officer. * By Jiezhelle * Lizardo * 10/22/2026 * News Vitaquest is entering an exciting new chapter with Martin Gargiule joining as Chief Financial Officer. Explore how his 25-plus years of financial leadership experience will support the company's strategic vision. Vitaquest International LLC is pleased to welcome Martin Gargiule as its new Chief Financial Officer, effective October 12, 2026. With more than 25 years of financial leadership experience across the consumer health, pharmaceutical, and manufacturing industries, Martin brings valuable expertise to Vitaquest as the company continues to invest in its people, capabilities, and long-term growth. Martin's appointment is part of Vitaquest's continued focus on strengthening its executive leadership team. Following the appointment of CEO Tim Condron in April and Chief Commercial Officer Luigi Cappello in September, his addition supports the company's strategic priorities of enhancing customer-centricity, accelerating innovation, and remaining an employer of choice. Bringing financial expertise to Vitaquest. Throughout his career, Martin has helped organizations navigate growth, improve financial operations, and build the systems needed to support long-term success. Before joining Vitaquest, Martin served as Vice President of Finance and Corporate Controller at Spectrum Vascular, a medical device manufacturer. In this role, he oversaw accounting, finance, IT, and human resources, led the implementation of a new enterprise resource planning (ERP) system, and managed the financial integration of two acquisitions. He previously held leadership positions as Chief Financial Officer at Douglas Electrical Components and Vice President of Finance at Advantice Health, where he supported business growth and operational improvements. This combination of financial and operational experience will be especially valuable as Vitaquest continues expanding its manufacturing capabilities and investing in solutions that help its customers succeed. Supporting Vitaquest's Next chapter of growth. As Vitaquest celebrates its 50th anniversary in 2027, the company remains focused on building a strong foundation for the future. "Building the right leadership team has been one of my top priorities since joining Vitaquest, and Martin is an outstanding addition to that team," said Tim Condron, CEO of Vitaquest. "He has spent his career building the financial discipline, systems, and insight that allow manufacturing businesses to grow with confidence." Martin shares that enthusiasm for Vitaquest's future and the opportunities ahead. "Vitaquest pairs a long-standing reputation for quality with a clear vision for where the company is headed," said Gargiule. "I'm excited to join Tim and the leadership team at a time of real momentum." With Martin joining the executive team, Vitaquest continues to strengthen the leadership, resources, and expertise needed to support its customers, employees, and partners. Please join Vitaquest in welcoming Martin to Vitaquest as Vitaquest continue Delivering What's Next in the nutraceutical industry. Jiezhelle. Lizardo. Marketing Manager. Jiezhelle Lizardo, the Marketing Manager at Vitaquest, has over 10 years of experience in marketing and brand strategy. She has been instrumental in driving Vitaquest's brand growth while championing collaboration and innovation across departments. Recognized as a Proud Champion Award winner, Jiezhelle also leads the company's Wellness Team and is an active participant in the Environmental, Social, and Governance Team as well as the Innovation Team, advancing Vitaquest's mission to inspire healthier lives through impactful initiatives and sustainable practices.
Vitaquest International appoints Martin Gargiule as Chief Financial Officer. Finance executive with more than 25 years across consumer health, pharmaceutical, and manufacturing businesses joins Vitaquest's growing leadership team. WEST CALDWELL, N.J., Oct. 22, 2026 (GLOBE NEWSWIRE) - Leading contract manufacturer Vitaquest International LLC today announced the appointment of Martin Gargiule as Chief Financial Officer, effective October 12, 2026. Gargiule brings more than 25 years of finance leadership across consumer health, pharmaceutical, and manufacturing companies, with deep experience building scalable finance organizations, implementing enterprise systems, and integrating growing businesses. Gargiule's appointment is the latest step in a deliberate build-out of Vitaquest's leadership team since Tim Condron was named Chief Executive Officer in April. Together with the recent appointment of Luigi Cappello as Chief Commercial Officer, these additions are designed to advance the three priorities guiding the company's 2026 strategy: driving customer-centricity in all aspects of the business, accelerating innovation that enables meaningful growth for its partners, and strengthening its position as an employer of choice. "Building the right leadership team has been one of my top priorities since joining Vitaquest, and Martin is an outstanding addition to that team," said Condron. "He has spent his career building the financial discipline, systems, and insight that allow manufacturing businesses to grow with confidence. As we continue investing in our capabilities and our people, his leadership will help ensure every investment we make translates into greater value for our customers." Gargiule joins Vitaquest from Spectrum Vascular, a medical device manufacturer, where he served as Vice President of Finance and Corporate Controller. There, he built the company's accounting, finance, IT, and human resources functions, led a QAD ERP implementation, and directed the financial integration of two acquisitions. He previously served as Chief Financial Officer of Douglas Electrical Components, a multi-site manufacturer of engineered components, and as Vice President of Finance at Advantice Health, a consumer health company focused on science-backed skincare brands, where he led the finance, IT, and HR functions through a period of significant growth. "Vitaquest pairs a long-standing reputation for quality with a clear vision for where the company is headed," said Gargiule. "I'm excited to join Tim and the leadership team at a time of real momentum. My focus will be on giving our teams the financial insight and infrastructure they need to move quickly, invest wisely, and deliver for our customers." Vitaquest offers a comprehensive range of services, from formulation design and product development to packaging and fulfillment, serving brands across multiple dosage forms including capsules, tablets, powders, and specialty formats. About Vitaquest International LLC Headquartered in West Caldwell, New Jersey, USA, Vitaquest International LLC is an industry-leading contract manufacturer and development partner for dietary supplements and functional foods. A leader in the design and development of new, standards-based quality initiatives, a comprehensive commitment to quality - called TotalQ(TM)- is at the core of Vitaquest as a company. With over 45 years of history, Vitaquest has the market insight, global reach, and scale of operations to support emerging and existing consumer brands from the idea to the store shelf - with flawless execution in every phase.
Spectrum Vascular has acquired Piccolo Medical, a developer of catheter guidance technology, to accelerate commercialisation of next-generation vascular access solutions. Piccolo CEO Augustus Shanahan will join Spectrum alongside his team to advance the company's 510(k)-cleared catheter guidance products. Piccolo's technology uses proprietary blood flow sensing to guide catheter tip placement in real time, eliminating the need for confirmatory chest X-rays. The company completed its first successful patient placements of the Nav+ Stylet in May 2026. Founded in 2016 and based in San Francisco, Piccolo was spun out of the Theranova medical device incubator. Spectrum Vascular, backed by SK Capital Partners, was formed through acquisitions of vascular access businesses from Cook Medical and AngioDynamics.
Spectrum Vascular acquires Piccolo Medical, accelerating launch of next-generation catheter navigation technology. More in financial: PR News WireThis post was originally published on this site WHITE PLAINS, N.Y., June 11, 2026 /PRNewswire/ - Spectrum Vascular ("Spectrum"), a leading provider of vascular access and medication management products, today announced the acquisition of Piccolo Medical ("Piccolo"), a developer of state-of-the-art catheter guidance products. The transaction deepens a partnership focused on bringing next-generation catheter guidance technology to market and marks a significant step forward in Spectrum's mission to deliver a complete, differentiated vascular access solution to the clinical community. Augustus Shanahan, CEO of Piccolo, will join Spectrum alongside the legacy Piccolo team. The group will advance development and commercialization of its 510(k)-cleared catheter guidance and location products, building upon an innovation roadmap more than a decade in the making. Piccolo's real-time catheter guidance utilizes proprietary blood flow sensing technology to precisely guide catheter tip placement, eliminating the need for confirmatory chest X-rays. Piccolo completed the first successful patient placements of its next-generation Nav+ Stylet in May 2026, marking the beginning of a new era in guided vascular access. "Joining the Spectrum team marks an exciting new chapter for Piccolo and for vascular access as a whole," said Augustus Shanahan. "I am incredibly proud of what the Piccolo team has built over the past decade, and together with Spectrum, we now have the platform, the portfolio, and the reach to set a new standard, delivering better outcomes for patients and real economic value for the hospitals that serve them." Kenneth Miller, CEO of Spectrum, commented, "The acquisition of Piccolo Medical represents an important milestone in our mission to transform vascular access. By combining Piccolo's breakthrough navigation technology with Spectrum's vascular access portfolio and commercial reach, we are uniquely positioned to accelerate innovation, improve patient care, and redefine the standard of care for clinicians worldwide." Together, Piccolo and Spectrum will accelerate commercialization, deepen integration with Spectrum's existing catheter portfolio, and scale the next-generation navigation platform. The combined organization is poised to set a new standard of care in vascular access with greater speed and reach. About Spectrum Vascular Spectrum Vascular, backed by SK Capital Partners, is a leading provider of vascular access and medication management products engineered to reduce healthcare-acquired infections. The Company's mission is to improve the lives of patients worldwide by providing caregivers with high quality, innovative products with exceptional customer service. Innovation has been a core strategic pillar throughout Spectrum's history and many of its products have been designed to deliver antimicrobial protection and thrombus reduction. Spectrum was formed through the acquisition of the vascular access businesses of Cook Medical and AngioDynamics. For more information, please visit www.spectrumvascular.com. About Piccolo Medical Piccolo Medical is a San Francisco-based medical device company and pioneer in catheter navigation and tip confirmation technology. Founded in 2016, Piccolo was spun out of the Theranova medical device incubator and has been funded through private investors as well as prestigious grant awards from The Eunice Kennedy Shriver National Institute of Child Health and Human Development. Piccolo is committed to developing and commercializing innovative vascular access technologies designed to improve clinical outcomes, streamline procedures, and reduce complications for patients. For more information, please visit www.piccolomedical.com. SOURCE Spectrum Vascular
Spectrum Vascular, a NYC-based medical device company, received an undisclosed investment from SK Capital Partners. The funds will be used to expand operations and development efforts. Spectrum Vascular, founded in 2023, specializes in vascular access and medication management products and was formed through the acquisition of the vascular access businesses of Cook Medical in 2023 and AngioDynamics in 2024.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
White Plains, NY
Founded
N/A
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs